A population-based study of stimulant drug treatment of ADHD and academic progress in children

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

A population-based study of stimulant drug treatment of ADHD and academic progress in children. / Zoëga, Helga; Rothman, Kenneth J; Huybrechts, Krista F; Ólafsson, Örn; Baldursson, Gísli; Almarsdóttir, Anna B; Jónsdóttir, Sólveig; Halldórsson, Matthías; Hernández-Diaz, Sonia; Valdimarsdóttir, Unnur A.

I: Pediatrics, Bind 130, Nr. 1, 07.2012, s. e53-62.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Zoëga, H, Rothman, KJ, Huybrechts, KF, Ólafsson, Ö, Baldursson, G, Almarsdóttir, AB, Jónsdóttir, S, Halldórsson, M, Hernández-Diaz, S & Valdimarsdóttir, UA 2012, 'A population-based study of stimulant drug treatment of ADHD and academic progress in children', Pediatrics, bind 130, nr. 1, s. e53-62. https://doi.org/10.1542/peds.2011-3493

APA

Zoëga, H., Rothman, K. J., Huybrechts, K. F., Ólafsson, Ö., Baldursson, G., Almarsdóttir, A. B., Jónsdóttir, S., Halldórsson, M., Hernández-Diaz, S., & Valdimarsdóttir, U. A. (2012). A population-based study of stimulant drug treatment of ADHD and academic progress in children. Pediatrics, 130(1), e53-62. https://doi.org/10.1542/peds.2011-3493

Vancouver

Zoëga H, Rothman KJ, Huybrechts KF, Ólafsson Ö, Baldursson G, Almarsdóttir AB o.a. A population-based study of stimulant drug treatment of ADHD and academic progress in children. Pediatrics. 2012 jul.;130(1):e53-62. https://doi.org/10.1542/peds.2011-3493

Author

Zoëga, Helga ; Rothman, Kenneth J ; Huybrechts, Krista F ; Ólafsson, Örn ; Baldursson, Gísli ; Almarsdóttir, Anna B ; Jónsdóttir, Sólveig ; Halldórsson, Matthías ; Hernández-Diaz, Sonia ; Valdimarsdóttir, Unnur A. / A population-based study of stimulant drug treatment of ADHD and academic progress in children. I: Pediatrics. 2012 ; Bind 130, Nr. 1. s. e53-62.

Bibtex

@article{1280a018ceb448ca90abbd0d1b5e33cb,
title = "A population-based study of stimulant drug treatment of ADHD and academic progress in children",
abstract = "OBJECTIVE: We evaluated the hypothesis that later start of stimulant treatment of attention-deficit/hyperactivity disorder adversely affects academic progress in mathematics and language arts among 9- to 12-year-old children.METHODS: We linked nationwide data from the Icelandic Medicines Registry and the Database of National Scholastic Examinations. The study population comprised 11,872 children born in 1994-1996 who took standardized tests in both fourth and seventh grade. We estimated the probability of academic decline (drop of ≥ 5.0 percentile points) according to drug exposure and timing of treatment start between examinations. To limit confounding by indication, we concentrated on children who started treatment either early or later, but at some point between fourth-grade and seventh-grade standardized tests.RESULTS: In contrast with nonmedicated children, children starting stimulant treatment between their fourth- and seventh-grade tests were more likely to decline in test performance. The crude probability of academic decline was 72.9% in mathematics and 42.9% in language arts for children with a treatment start 25 to 36 months after the fourth-grade test. Compared with those starting treatment earlier (≤ 12 months after tests), the multivariable adjusted risk ratio (RR) for decline was 1.7 (95% confidence interval [CI]: 1.2-2.4) in mathematics and 1.1 (95% CI: 0.7-1.8) in language arts. The adjusted RR of mathematics decline with later treatment was higher among girls (RR, 2.7; 95% CI: 1.2-6.0) than boys (RR, 1.4; 95% CI: 0.9-2.0).CONCLUSIONS: Later start of stimulant drug treatment of attention-deficit/hyperactivity disorder is associated with academic decline in mathematics.",
keywords = "Achievement, Age Factors, Amphetamine, Atomoxetine Hydrochloride, Attention Deficit Disorder with Hyperactivity, Central Nervous System Stimulants, Child, Educational Measurement, Female, Humans, Iceland, Language Arts, Male, Mathematics, Methylphenidate, Multivariate Analysis, Odds Ratio, Propylamines, Registries, Sex Factors, Treatment Outcome, Evaluation Studies, Journal Article, Research Support, Non-U.S. Gov't",
author = "Helga Zo{\"e}ga and Rothman, {Kenneth J} and Huybrechts, {Krista F} and {\"O}rn {\'O}lafsson and G{\'i}sli Baldursson and Almarsd{\'o}ttir, {Anna B} and S{\'o}lveig J{\'o}nsd{\'o}ttir and Matth{\'i}as Halld{\'o}rsson and Sonia Hern{\'a}ndez-Diaz and Valdimarsd{\'o}ttir, {Unnur A}",
year = "2012",
month = jul,
doi = "10.1542/peds.2011-3493",
language = "English",
volume = "130",
pages = "e53--62",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "1",

}

RIS

TY - JOUR

T1 - A population-based study of stimulant drug treatment of ADHD and academic progress in children

AU - Zoëga, Helga

AU - Rothman, Kenneth J

AU - Huybrechts, Krista F

AU - Ólafsson, Örn

AU - Baldursson, Gísli

AU - Almarsdóttir, Anna B

AU - Jónsdóttir, Sólveig

AU - Halldórsson, Matthías

AU - Hernández-Diaz, Sonia

AU - Valdimarsdóttir, Unnur A

PY - 2012/7

Y1 - 2012/7

N2 - OBJECTIVE: We evaluated the hypothesis that later start of stimulant treatment of attention-deficit/hyperactivity disorder adversely affects academic progress in mathematics and language arts among 9- to 12-year-old children.METHODS: We linked nationwide data from the Icelandic Medicines Registry and the Database of National Scholastic Examinations. The study population comprised 11,872 children born in 1994-1996 who took standardized tests in both fourth and seventh grade. We estimated the probability of academic decline (drop of ≥ 5.0 percentile points) according to drug exposure and timing of treatment start between examinations. To limit confounding by indication, we concentrated on children who started treatment either early or later, but at some point between fourth-grade and seventh-grade standardized tests.RESULTS: In contrast with nonmedicated children, children starting stimulant treatment between their fourth- and seventh-grade tests were more likely to decline in test performance. The crude probability of academic decline was 72.9% in mathematics and 42.9% in language arts for children with a treatment start 25 to 36 months after the fourth-grade test. Compared with those starting treatment earlier (≤ 12 months after tests), the multivariable adjusted risk ratio (RR) for decline was 1.7 (95% confidence interval [CI]: 1.2-2.4) in mathematics and 1.1 (95% CI: 0.7-1.8) in language arts. The adjusted RR of mathematics decline with later treatment was higher among girls (RR, 2.7; 95% CI: 1.2-6.0) than boys (RR, 1.4; 95% CI: 0.9-2.0).CONCLUSIONS: Later start of stimulant drug treatment of attention-deficit/hyperactivity disorder is associated with academic decline in mathematics.

AB - OBJECTIVE: We evaluated the hypothesis that later start of stimulant treatment of attention-deficit/hyperactivity disorder adversely affects academic progress in mathematics and language arts among 9- to 12-year-old children.METHODS: We linked nationwide data from the Icelandic Medicines Registry and the Database of National Scholastic Examinations. The study population comprised 11,872 children born in 1994-1996 who took standardized tests in both fourth and seventh grade. We estimated the probability of academic decline (drop of ≥ 5.0 percentile points) according to drug exposure and timing of treatment start between examinations. To limit confounding by indication, we concentrated on children who started treatment either early or later, but at some point between fourth-grade and seventh-grade standardized tests.RESULTS: In contrast with nonmedicated children, children starting stimulant treatment between their fourth- and seventh-grade tests were more likely to decline in test performance. The crude probability of academic decline was 72.9% in mathematics and 42.9% in language arts for children with a treatment start 25 to 36 months after the fourth-grade test. Compared with those starting treatment earlier (≤ 12 months after tests), the multivariable adjusted risk ratio (RR) for decline was 1.7 (95% confidence interval [CI]: 1.2-2.4) in mathematics and 1.1 (95% CI: 0.7-1.8) in language arts. The adjusted RR of mathematics decline with later treatment was higher among girls (RR, 2.7; 95% CI: 1.2-6.0) than boys (RR, 1.4; 95% CI: 0.9-2.0).CONCLUSIONS: Later start of stimulant drug treatment of attention-deficit/hyperactivity disorder is associated with academic decline in mathematics.

KW - Achievement

KW - Age Factors

KW - Amphetamine

KW - Atomoxetine Hydrochloride

KW - Attention Deficit Disorder with Hyperactivity

KW - Central Nervous System Stimulants

KW - Child

KW - Educational Measurement

KW - Female

KW - Humans

KW - Iceland

KW - Language Arts

KW - Male

KW - Mathematics

KW - Methylphenidate

KW - Multivariate Analysis

KW - Odds Ratio

KW - Propylamines

KW - Registries

KW - Sex Factors

KW - Treatment Outcome

KW - Evaluation Studies

KW - Journal Article

KW - Research Support, Non-U.S. Gov't

U2 - 10.1542/peds.2011-3493

DO - 10.1542/peds.2011-3493

M3 - Journal article

C2 - 22732167

VL - 130

SP - e53-62

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 1

ER -

ID: 170602193